Penn Medicine Provider
Radiology
Paco E. Bravo, MD
Accepting new patients
Sees patients age 18 and up

About me

  • Director of Nuclear Cardiology and Cardiovascular Molecular Imaging
  • Assistant Professor of Radiology at the Hospital of the University of Pennsylvania
  • Assistant Professor of Radiology in Medicine

Education and training

  • Medical School: Universidad del Valle
  • Residency: University of Alabama at Birmingham (UAB Hospital)
  • Residency: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital
  • Fellowship: University of Washington Hospital and Clinics
  • Fellowship: Massachusetts General Hospital/Brigham and Women’s Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Bravo is a Penn Medicine physician.

Qualifications and experience

My research

Bravo PE, Vita TS, Taqueti V, Veillet-Chowdhury M, Steigner M, Skali H, Dorbala S, Di Carli MF, Blankstein R. Detection of Myocardial Inflammation by T2-weighted Imaging on Cardiac MRI versus FDG PET Among Patients with Suspected Cardiac Sarcoidosis. , 22nd Annual Scientific Session of the American Society of Nuclear Cardiology: 2017


Bravo PE, Fujijura K, Kijewski MF, Jacob S, Sticka W, Dubey S, Belanger A, Park M, Di Carli MF, Falk RH, Dorbala S. Apical Sparing of Longitudinal Strain Cannot be Explained by Regional Differences in Florbetapir Retention in Cardiac Amyloidosis. ASNC, 22nd Annual Scientific Session. , 22nd Annual Scientific Session of the American Society of Nuclear Cardiology: 2017


Bravo PE, Raghu G, Rosenthal DG, Elman S, Petek BJ, Soine LA, Maki JH, Branch KR, Masri SC, Patton KK, Caldwell JH, Krieger EV Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging , International Journal of Cardiology, 15(241): 2017,457-462


Gupta A, Taqueti VR, van de Hoef TP, Bajaj NS, Bravo PE, Murthy VL, Osborne MT, Seidelmann SB, Vita TS, Bibbo CF, Harrington M, Hainer J, Rimoldi O, Dorbala S, Bhatt DL, Blankstein R, Camici PG, Di Carli MF Integrated Non-invasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients with Stable Coronary Artery Disease , Circulation, 136(24): 2017,2325-2336


Bravo PE, Di Carli MF, Dorbala S Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies , Heart Failure Reviews, 22(4): 2017,455-464


Bravo PE, Dorbala S. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis. , Current Cardiology Reports, 19(7): 2017,59


Bravo PE, Taqueti VR Cardiac MRI vs. PET for the Evaluation of Cardiac Sarcoidosis: Consider MRI First , American College of Cardiology: 2017


Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP Apparent Left Ventricular Cavity Dilatation during PET/CT in Hypertrophic Cardiomyopathy: Clinical Predictors and Potential Mechanisms , Journal of Nuclear Cardiology, 23(6): 2016,1304-1314


Seidelmann SB, Claggett B, Bravo PE, Gupta A, Farhad H, Klein BE, Klein, R, Di Carli MF, Solomon SD Retinal Vessel Calibers in Predicting Longterm Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study , Circulation, 134(18): 2016,1328-1338


Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti V, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity , J Nucl Cardiol, 25(4): 2016,1136-1146


View all publications